Abstract
The members of MAGE gene family are highly expressed in human hepatocellular carcinoma (HCC). In the present study, we tested the tumour-specific MAGE-1 and MAGE-3 transcripts in the peripheral blood of HCC patients by nested RT–PCR to detect the circulating tumour cells and evaluate their potential clinical implication. Of 30 HCC patients, the positive rate of MAGE-1 and MAGE-3 transcripts was 43.3% (13 out of 30) and 33.3% (10 out of 30) in PBMC samples, whilst the positive rate was 70% (21 out of 30) and 53.3% (16 out of 30) in the resected HCC tissue samples, respectively. The positivity for at least one MAGE gene transcript was 63.3% (19 out of 30) in PBMC samples of HCC patients and 83.3% (25 out of 30) in the resected HCC tissue samples. MAGE-1 and/or MAGE-3 mRNA were not detected in the PBMC of those patients from whom the resected HCC tissues were MAGE-1 or MAGE-3 mRNA negative, nor in the 25 PBMC samples from healthy donors. The detection of MAGE transcripts in PBMC was correlated with the advanced stages and tumour size of the HCC, being 82.4% (14 out of 17) in tumour stages III and IVa, 56.6% (five out of nine) in stage II, and null (nought out of four) in stage I. The serum α-FP in 33.3% (10 out of 30) of HCC patients was normal or slightly elevated (<40 ng ml−1). However, six of these 10 patients (α-FP <40 ng ml−1) were MAGE-1 and /or MAGE-3 mRNA positive in their PBMC. The follow-up survey of MAGE mRNA in PBMC was performed in 12 patients. Seven patients with persistent MAGE-1 and/or MAGE-3 mRNA positive or from negative turned to positive died because of metastasis and/or recurrence. In striking contrast, all four patients with MAGE-1 and/or MAGE-3 mRNA from positive turned to negative and one patient with persistent MAGE-3 transcript negative are alive after last test. Collectively, detection of MAGE transcripts with follow-up survey in PBMC is a feasible and reliable assay for the early prediction of the relapse and prognosis of the HCC patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Brossart P, Keilholz U, Willhauck M, Scheibenbogen C, Mohler T, Hunstein W (1993) Hematogenous spread of malignant melanoma cells in different stages of disease. J Invest Dermatol 101: 887–889
Cai SL, Chen HS, Wang Y, Zhao HR, Peng JR, Pang XW, Gong SY, Zhu JY, Cong X, Wang Y, Rui JA, Leng XS, Du RY, Chen WF (1999) Expression of MAGE-1 gene in hepatocellular carcinoma. Natl Med J China 79: 668–672
Cai SL, Zhao HT, Leng XS, Cheng JH, Gong SY, Peng JR, Cong X, Wang Y, Rui JA, Hui YZ, Du RY, Chen WF (2000) Melanoma antigen-3 expression in human hepatocellular carcinoma. Chin J Surg 38: 693–696
Chen CH, Huang GT, Lee HS, Yang PM, Yan MD, Chen DS, Sheu JC (1999) High frequency of expression of MAGE genes in human hepatocellular carcinoma. Liver 19: 110–114
Chou HC, Sheu JC, Huang GT, Wang JT, Chen DS (1994) Albumin messenger RNA is not specific for circulating hepatoma cells. Gastroenterology 107: 630–631
Dall P, Heider KH, Sinn HP, Skroch-Angel P, Adolf G, Kaufmann M, Herrlich P, Ponta H (1995) Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Int J Cancer 60: 471–477
De Plaen E, Arden K, Traversari C, Gaforio JJ, Szikora JP, De Smet C, Brasseur F, van der Bruggen P, Lethe B, Lurquin C, Brasseur R, Chomez P, De Backer O, Cavenee W, Boon T (1994) Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 40: 360–369
Foss AJ, Guille MJ, Occleston NL, Hykin PG, Hungerford JL, Lightman S (1995) The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction. Br J Cancer 72: 155–159
Hillaire S, Barbu V, Boucher E, Moukhtar M, Poupon R (1994) Albumin messenger RNA as a marker of circulating hepatocytes in hepatocelular carcinoma. Gastroenterology 106: 239–242
Hoon DS, Wang Y, Dale PS, Conrad AJ, Schmid P, Garrison D, Kuo C, Foshag LJ, Nizze AJ, Morton DL (1995) Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 13: 2109–2116
Israeli RS, Miller Jr WH, Su SL, Powell CT, Fair WR, Samadi DS, Huryk RF, DeBlasio A, Edwards ET, Wise GJ, Heston WDW (1994) Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumour cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res 54: 6306–6310
Israeli RS, Miller Jr WH, Su SL, Samadi DS, Powell CT, Heston WD, Wise GJ, Fair WR (1995) Sensitive detection of prostatic hematogenous tumour cell dissemination using prostate specific antigen and prostate specific membrane-derived primers in the polymerase chain reaction. J Urol 53: (3 Pt 1) 73–77
Jiang SY, Shyu RY, Huang MF, Tang HS, Young TH, Roffler SR, Chiou YS, Yeh MY (1997) Detection of alphafetoprotein expressing cells in the blood of patients with hepatoma and hepatitis. Br J Cancer 75: 928–933
Kar S, Carr BI (1995) Detection of liver cells in peripheral blood of patients with advanced hepatocelular carcinoma. Hepatology 21: 403–407
Komeda T, Fukuda Y, Sando T, Kita R, Furukawa M, Nishida N, Amenomori M, Nakao K (1995) Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer 75: 2214–2219
Kruger WH, Stockschlader M, Hennings S, Aschenbrenner M, Gruber M, Gutensohn K, Loliger C, Gieseking F, Jonat W, Zander AR (1996) Detection of cancer cells in peripheral blood stem cells of women with breast cancer by RT-PCR and cell culture. Bone Marrow Transplant 18: Suppl 1 S18–S20
Lemoine A, Le Bricon T, Salvucci M, Azoulay D, Pham P, Raccuia J, Bismuth H, Debuire B (1997) Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery. Ann Surg 226: 43–50
Liver Cancer Study Group of Japan (1989) TNM classification for hepatocellular carcinoma by Liver Cancer Study Group of Japan. World J Surg 13: 212
Lucas S, De Smet, Arden KC, Viars CS, Lethe B, Lurquin C, Boon T (1998) Identification of a new MAGE gene with tumour-specific expression by representational difference analysis. Cancer Res 58: 743–752
Lurquin C, De Smet, Brasseur F, Muscatelli F, Martelange V, De Plaen E, Brasseur R, Monaco AP, Boon T (1997) Two members of the human MAGEB gene family located in Xp.21.3 are expressed in tumours of various histological origins. Genomics 46: 397–408
Malek L, Jerome N, Herve Z, Abdelmajid S, Corinne V, Giovanna V, Karine P, Monique T, Frederique C, Stanislas P, Dominique F, Bernard L, Christian B, Paterlini PB (1999) Liver resection and needle liver biopsy cause hematogeneous dissemination of liver cells. Hepatology 29: 879–882
Matsumura M, Niwa Y, Kato N, Komatsu Y, Shiina S, Kawabe T, Kawase T, Toyoshima H, Ihori M, Shiratori Y, Omata M (1994) Detection of alpha-fetoprotein mRNA, an indicator of haematogeous spreading hepatocellular carcinoma, in the circulation: A possiple predictor of metastatic hepatocellular carcinoma. Hepatology 20: 1418–1425
Miyajima Y, Horibe K, Fukuda M, Matsumoto K, Numata S, Mori H, Kato K (1996) Sequential detection of tumour cells in the peripheral blood and bone marrow of patients with stage IV neuroblastoma by the reverse transcription-polymerase chain reaction for tyrosine hydroxylase mRNA. Cancer 77: 1214–1219
Miyamoto A, Fujiwara Y, Sakon M, Nagano H, Sugita Y, Kondo M, Eguchi H, Dono K, Umeshita K, Nakamori S, Monden M (2000) Development of a multiple-marker RT-PCR assay for detection of micrometastases of hepatocellular carcinoma. Dig Dis Sci 45: 1376–1382
Mori M, Mimori K, Ueo H, Karimine N, Barnard GF, Sugimachi K, Akiyoshi T (1996) Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease. Int J Cancer 63: 739–743
Muscatelli F, Walker AP, De Plaen E, Stafford AN, Monaco AP (1995) Isolation and characterization of a new MAGE gene family in the Xp21.3 region. Proc Natl Acad Sci USA 92: 4987–4991
Naito H, Kuzumaki N, Uchino J, Kobayashi R, Shikano T, Ishikawa Y, Matsumoto S (1991) Detection of tyrosine hydroxylase mRNA and minimal meuroblastoma cells by the reverse transcription-polymerase chain reaction. Eur J Cancer 27: 762–765
Negrin RS, Blume KG (1991) The use of the polymerase chain reaction for the detection of minimal residual malignant disease. Blood 78: 255–258
Smith B, Selby P, Southgate J, Pittman K, Bradley C, Blair GE (1991) Detection of melanoma cells in peripheral blood by means of reverse transcription and polymerase chain reaction. Lancet 338: 1227–1229
Tahara K, Mori M, Sadanaga N, Sakamoto Y, Kitano S, Makuuchi M (1999) Expression of the MAGE gene family in human hepatocellular carcinoma. Cancer 85: 1234–1240
van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254: 1643–1647
Wong IH-N, Leung T, Ho S, Lau WY, Chan M, Johnson PJ (1997) Semiquantitation of circulating hepatocelular carcinoma cells by reverse transcriptase polymerase chain reaction. Br J Cancer 76: 629–633
Yamashita N, Ishibashi H, Hayashida K, Kudo J, Takenaka K, Itoh K, Niho Y (1996) High frequency of the MAGE-1 gene expression in hepatocellular carcinoma. Hepatology 24: 1437–1440
Acknowledgements
This work was supported by 973 Program in China, Grant No.: G1999053904; Ludwig Institute for Cancer Research Grant KSP No. 003; Beijing Municipal Government Foundation for Natural Sciences, Grant No.: 7001002.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Mou, DC., Cai, SL., Peng, JR. et al. Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells. Br J Cancer 86, 110–116 (2002). https://doi.org/10.1038/sj.bjc.6600016
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6600016
Keywords
This article is cited by
-
Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
Molecular Cancer (2019)
-
Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
Journal of Experimental & Clinical Cancer Research (2018)
-
In vivo enhancement of the MAGE-specific cellular immune response by a recombinant MAGE1-MAGE3-TBHSP70 tumor vaccine
Cancer Cell International (2016)
-
Melanoma-associated antigen genes: a new trend to predict the prognosis of breast cancer patients
Medical Oncology (2014)
-
Cyclooxygenase-2 single-nucleotide polymorphisms and hepatocellular carcinoma in Egypt
Molecular Biology Reports (2014)